STAAR Surgical Company (STAA)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 13,986 21,776 16,613 15,298 21,347 19,444 24,889 31,863 38,755 37,824 33,582 29,111 24,501 22,906 20,778 11,039 5,913 8,965 7,461 12,547
Total assets US$ in thousands 510 537,590 512,745 492,535 488,692 471,521 440,651 418,905 418,818 394,676 376,025 351,177 345,778 324,605 294,438 265,806 257,416 234,698 218,039 206,788
ROA 2,742.35% 4.05% 3.24% 3.11% 4.37% 4.12% 5.65% 7.61% 9.25% 9.58% 8.93% 8.29% 7.09% 7.06% 7.06% 4.15% 2.30% 3.82% 3.42% 6.07%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $13,986K ÷ $510K
= 2,742.35%

STAAR Surgical Company’s return on assets (ROA) has shown fluctuations over the past few years, ranging from as low as 2.30% on December 31, 2020, to a high of 9.58% on September 30, 2022. The ROA improved significantly from the end of 2022 through the first half of 2023, reaching a peak of 9.25% on December 31, 2022. However, there was a notable drop in ROA to 2,742.35% on December 31, 2024, which might be attributed to data discrepancies or calculation errors.

Overall, the trend in ROA for STAAR Surgical Company indicates some level of volatility, with occasional spikes and dips in performance. Investors and stakeholders should closely monitor the company’s asset utilization efficiency and profitability to assess its financial health and sustainability.


Peer comparison

Dec 31, 2024